EFFECT OF DIPYRONE, ACETYLSALICYLIC-ACID AND ACETAMINOPHEN ON HUMAN NEUTROPHIL CHEMOTAXIS

被引:16
作者
MATZNER, Y [1 ]
DREXLER, R [1 ]
LEVY, M [1 ]
机构
[1] HADASSH UNIV HOSP,DEPT MED A,CLIN PHARMACOL UNIT,IL-91120 JERUSALEM,ISRAEL
关键词
D O I
10.1111/j.1365-2362.1984.tb01210.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:440 / 443
页数:4
相关论文
共 22 条
[1]  
ALI M, 1977, J LAB CLIN MED, V89, P868
[2]  
AUSTIN TW, 1978, CAN MED ASSOC J, V118, P493
[3]  
BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
[4]   RECEPTOR-DIRECTED INHIBITION OF CHEMOTACTIC FACTOR-INDUCED NEUTROPHIL HYPERACTIVITY BY PYRAZOLON DERIVATIVES - DEFINITION OF A CHEMOTACTIC PEPTIDE ANTAGONIST [J].
DAHINDEN, C ;
FEHR, J .
JOURNAL OF CLINICAL INVESTIGATION, 1980, 66 (05) :884-891
[5]   EFFECTS OF ANTIINFLAMMATORY DRUGS ON PROSTAGLANDIN BIOSYNTHESIS [J].
FLOWER, R ;
VANE, JR ;
GRYGLEWS.R ;
HERBACZY.K .
NATURE-NEW BIOLOGY, 1972, 238 (82) :104-&
[6]  
FUSTER V, 1981, MAYO CLIN PROC, V56, P185
[7]   CHEMOTACTIC ROLE FOR PROSTAGLANDINS RELEASED FROM POLYMORPHONUCLEAR LEUKOCYTES DURING PHAGOCYTOSIS [J].
HIGGS, GA ;
MCCALL, E ;
YOULTEN, LJF .
BRITISH JOURNAL OF PHARMACOLOGY, 1975, 53 (04) :539-546
[8]  
Katler E, 1977, Inflammation, V2, P295, DOI 10.1007/BF00921009
[9]   ENHANCED POLYMORPHONUCLEAR CHEMOTAXIS - A COMMON FEATURE OF DISEASES RESPONSIVE TO COLCHICINE [J].
LEVY, M ;
EHRENFELD, M ;
GALLILY, R ;
ELIAKIM, M .
MEDICAL HYPOTHESES, 1981, 7 (01) :15-20
[10]  
MATZNER Y, 1983, IMMUNOLOGY, V49, P131